Amplia targets ovarian cancer in new clinical protein inhibitor trial
--------------------------------------------------------------------
Source: The Age
Published: 2026-05-08 13:57 UTC+10:00
Section: Business / Companies
Factuality Score: 100
Opinion Category: Neutral
Topics: Health, Law & Courts, Elections, Drugs, Business & Economy, Crime & Justice
--------------------------------------------------------------------
Snippet:
Amplia Therapeutics is aggressively broadening its clinical reach, unveiling a major new collaboration to throw its lead drug candidate, narmafotinib, into the ring against ovarian cancer.
--------------------------------------------------------------------